MDR: Misuse of Drugs Regulations, 2001
Under the Misuse of Drugs Regulations 2001, cannabis-based medicinal products for use in humans (CBMPs) are classed as schedule 2.
In 2001, the Misuse of Drugs Regulations (MDR) were introduced in the UK to expand further on the 1971 Misuse of Drugs Act. The MDR determines the circumstances in which it is legal to possess, produce, supply, and transport controlled drugs. The MDR is also in charge of legalising the prescription of licensed products by authorised prescribers.
Who sits on the Misuse of Drugs Committee?
The Misuse of Drugs Regulations also established the Misuse of Drugs Advisory Council (MDAC), which is responsible for advising the government on drug control matters. The council includes professionals from various fields such as medicine, pharmacology, law enforcement, and social sciences. Their expertise and diverse backgrounds ensure that decisions regarding controlled drugs are based on sound scientific evidence and reflect a range of perspectives.
To find out more about the Misuse of Drug Regulations, click here.
If you would like to learn more about medical cannabis in the UK, Releaf is here to help.